Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV003412947 | SCV004123567 | uncertain significance | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | DHDDS: PM2 |
Labcorp Genetics |
RCV003525406 | SCV004312459 | pathogenic | Retinitis pigmentosa 59 | 2023-05-30 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with congenital disorders of glycosylation (PMID: 27343064). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp64*) in the DHDDS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DHDDS are known to be pathogenic (PMID: 24664742). |